Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-09-02

AUTHORS

Cécile Gérard, Nathalie Bleyzac, Pascal Girard, Gilles Freyer, Yves Bertrand, Michel Tod

ABSTRACT

ABSTRACTPurposeCyclosporin is administered by intermittent infusions (II) or continuous infusions (CI) to prevent acute graft-versus-host disease (aGVHD). Because cyclosporin disposition is nonlinear, organ exposure may be higher after II than after CI, but saturation of receptors must be accounted for. The aim of the study was to compare both types of administration using a mechanistic model.MethodsA physiologically based pharmacokinetic model was developed to estimate cyclosporin exposure and receptor occupancies (RO) in aGVHD target organs and kidneys and to compare these estimations in pediatric patients that received cyclosporin either by II or CI. The relevant biological parameters were based on a clinical study in 2 groups of pediatric patients that received cyclosporin either by II (n = 31) or CI (n = 30).ResultsSimulations showed that the exposure to cyclosporin in the interstitial fluid of aGVHD target organs was greater at day 1 after II than after CI. In kidneys, the opposite order was observed. AUCRO in all organs was greater after CI than after II. The therapeutic index (the ratio of AUCRO in blood to AUCRO in kidneys) was greater with CI than with II.ConclusionsCI may be slightly more favorable than II for aGVHD prevention. More... »

PAGES

2602-2613

References to SciGraph publications

  • 1997-04-01. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT) in BONE MARROW TRANSPLANTATION
  • 2003-10-01. Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors in BONE MARROW TRANSPLANTATION
  • 1999-12-01. Physiologically Based Pharmacokinetics of Cyclosporine A: Reevaluation of Dose–Nonlinear Kinetics in Rats in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2001-05-01. Haematopoietic cell transplantation as immunotherapy in NATURE
  • 1999-07. Developmental pharmacodynamics of cyclosporine in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1999-09-01. Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia in BONE MARROW TRANSPLANTATION
  • 2006-09-18. Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients in BONE MARROW TRANSPLANTATION
  • 2006-09. Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children in CLINICAL PHARMACOKINETICS
  • 2003-10-16. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors in BONE MARROW TRANSPLANTATION
  • 2006-10. Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children in CLINICAL PHARMACOKINETICS
  • 1998-09-01. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis in BONE MARROW TRANSPLANTATION
  • 1994-10-01. Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 1991-02-01. Physiologic modeling of cyclosporin kinetics in rat and man in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2007-05. Exposure-Effect Population Model of Inolimomab, a Monoclonal Antibody Administered in First-Line Treatment for Acute Graft-Versus-Host Disease in CLINICAL PHARMACOKINETICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1

    DOI

    http://dx.doi.org/10.1007/s11095-010-0252-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1018143837

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20811933


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Area Under Curve", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cyclosporine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Administration Schedule", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Graft vs Host Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoietic Stem Cell Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tissue Distribution", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "Universit\u00e9 de Lyon, F-69003, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "G\u00e9rard", 
            "givenName": "C\u00e9cile", 
            "id": "sg:person.0660130455.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660130455.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Facult\u00e9 de M\u00e9decine, Universit\u00e9 Lyon 1, CNRS UMR5558, F-69008, Lyon, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine, Universit\u00e9 Lyon 1, CNRS UMR5558, F-69008, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bleyzac", 
            "givenName": "Nathalie", 
            "id": "sg:person.01250741512.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250741512.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "Universit\u00e9 de Lyon, F-69003, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Girard", 
            "givenName": "Pascal", 
            "id": "sg:person.012661201622.56", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661201622.56"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "Universit\u00e9 de Lyon, F-69003, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Freyer", 
            "givenName": "Gilles", 
            "id": "sg:person.0636233052.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636233052.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Lyon, France", 
              "id": "http://www.grid.ac/institutes/grid.452431.5", 
              "name": [
                "Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bertrand", 
            "givenName": "Yves", 
            "id": "sg:person.01077622701.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pharmacie, H\u00f4pital de la Croix-Rousse, Hospices Civils de Lyon, 103 Grande rue de la Croix-Rousse, 69317, Lyon cedex 04, France", 
              "id": "http://www.grid.ac/institutes/grid.413306.3", 
              "name": [
                "Universit\u00e9 de Lyon, F-69003, Lyon, France", 
                "Facult\u00e9 de M\u00e9decine Lyon Sud, Universit\u00e9 Lyon 1, EA3738, CTO, F-69600, Oullins, France", 
                "Pharmacie, H\u00f4pital de la Croix-Rousse, Hospices Civils de Lyon, 103 Grande rue de la Croix-Rousse, 69317, Lyon cedex 04, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tod", 
            "givenName": "Michel", 
            "id": "sg:person.0763711421.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763711421.46"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.bmt.1701396", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043707730", 
              "https://doi.org/10.1038/sj.bmt.1701396"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200645090-00005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017122603", 
              "https://doi.org/10.2165/00003088-200645090-00005"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1701954", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039560833", 
              "https://doi.org/10.1038/sj.bmt.1701954"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02353860", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015648303", 
              "https://doi.org/10.1007/bf02353860"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01062191", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052427388", 
              "https://doi.org/10.1007/bf01062191"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0009-9236(99)70055-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001636599", 
              "https://doi.org/10.1016/s0009-9236(99)70055-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1020978509566", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031758240", 
              "https://doi.org/10.1023/a:1020978509566"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1700745", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005934101", 
              "https://doi.org/10.1038/sj.bmt.1700745"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35077251", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023027862", 
              "https://doi.org/10.1038/35077251"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1705481", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050679665", 
              "https://doi.org/10.1038/sj.bmt.1705481"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1704213", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038017388", 
              "https://doi.org/10.1038/sj.bmt.1704213"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200746050-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016219511", 
              "https://doi.org/10.2165/00003088-200746050-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1704239", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002246124", 
              "https://doi.org/10.1038/sj.bmt.1704239"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200645100-00005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037331185", 
              "https://doi.org/10.2165/00003088-200645100-00005"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-09-02", 
        "datePublishedReg": "2010-09-02", 
        "description": "ABSTRACTPurposeCyclosporin is administered by intermittent infusions (II) or continuous infusions (CI) to prevent acute graft-versus-host disease (aGVHD). Because cyclosporin disposition is nonlinear, organ exposure may be higher after II than after CI, but saturation of receptors must be accounted for. The aim of the study was to compare both types of administration using a mechanistic model.MethodsA physiologically based pharmacokinetic model was developed to estimate cyclosporin exposure and receptor occupancies (RO) in aGVHD target organs and kidneys and to compare these estimations in pediatric patients that received cyclosporin either by II or CI. The relevant biological parameters were based on a clinical study in 2 groups of pediatric patients that received cyclosporin either by II (n\u2009=\u200931) or CI (n\u2009=\u200930).ResultsSimulations showed that the exposure to cyclosporin in the interstitial fluid of aGVHD target organs was greater at day 1 after II than after CI. In kidneys, the opposite order was observed. AUCRO in all organs was greater after CI than after II. The therapeutic index (the ratio of AUCRO in blood to AUCRO in kidneys) was greater with CI than with II.ConclusionsCI may be slightly more favorable than II for aGVHD prevention.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s11095-010-0252-1", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1094644", 
            "issn": [
              "0724-8741", 
              "1573-904X"
            ], 
            "name": "Pharmaceutical Research", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "12", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "27"
          }
        ], 
        "keywords": [
          "continuous infusion", 
          "pediatric patients", 
          "intermittent infusion", 
          "receptor occupancy", 
          "pediatric hematopoietic stem cell transplantation", 
          "organ exposure", 
          "hematopoietic stem cell transplantation", 
          "stem cell transplantation", 
          "saturation of receptors", 
          "type of administration", 
          "acute graft", 
          "cyclosporin exposure", 
          "host disease", 
          "cell transplantation", 
          "clinical studies", 
          "target organs", 
          "therapeutic index", 
          "day 1", 
          "pharmacokinetic model", 
          "PBPK model", 
          "cyclosporin", 
          "patients", 
          "relevant biological parameters", 
          "infusion", 
          "kidney", 
          "exposure", 
          "organs", 
          "interstitial fluid", 
          "transplantation", 
          "graft", 
          "disease", 
          "administration", 
          "prevention", 
          "receptors", 
          "biological parameters", 
          "study", 
          "group", 
          "aim", 
          "opposite order", 
          "index", 
          "disposition", 
          "schedule", 
          "fluid", 
          "types", 
          "model", 
          "saturation", 
          "analysis", 
          "ResultsSimulations", 
          "influence", 
          "occupancy", 
          "parameters", 
          "order", 
          "mechanistic model", 
          "estimation"
        ], 
        "name": "Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model", 
        "pagination": "2602-2613", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1018143837"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s11095-010-0252-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20811933"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s11095-010-0252-1", 
          "https://app.dimensions.ai/details/publication/pub.1018143837"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_517.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s11095-010-0252-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11095-010-0252-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    262 TRIPLES      21 PREDICATES      104 URIs      82 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s11095-010-0252-1 schema:about N06a00518795e4180b994641bc82579ec
    2 N09f3b2af4d5a40e19b05fa3d46b3c9b7
    3 N20dd09cba6f04ae79d285a015964d14d
    4 N2cecbeb53e0d46638bb50d0c5e0def6e
    5 N552b49c8f2804bbda7270bf0385845c8
    6 N7becbbb0c1cf445c96e16acb628220c0
    7 N7f498f1e2fa74e3cab998661a6fed74a
    8 N862bb689b77e47d0a6bbd7bfd9ca84b6
    9 N8be64cbf8a56445c89ffd254e874375b
    10 Nba89ec5f6b2744fa97c56c9f5fdbbd87
    11 Ne63a424b16714c9682f21e9e6ec1c175
    12 anzsrc-for:11
    13 anzsrc-for:1115
    14 schema:author Nfab553ca4c4c483cb816880836519f30
    15 schema:citation sg:pub.10.1007/bf01062191
    16 sg:pub.10.1007/bf02353860
    17 sg:pub.10.1016/s0009-9236(99)70055-x
    18 sg:pub.10.1023/a:1020978509566
    19 sg:pub.10.1038/35077251
    20 sg:pub.10.1038/sj.bmt.1700745
    21 sg:pub.10.1038/sj.bmt.1701396
    22 sg:pub.10.1038/sj.bmt.1701954
    23 sg:pub.10.1038/sj.bmt.1704213
    24 sg:pub.10.1038/sj.bmt.1704239
    25 sg:pub.10.1038/sj.bmt.1705481
    26 sg:pub.10.2165/00003088-200645090-00005
    27 sg:pub.10.2165/00003088-200645100-00005
    28 sg:pub.10.2165/00003088-200746050-00004
    29 schema:datePublished 2010-09-02
    30 schema:datePublishedReg 2010-09-02
    31 schema:description ABSTRACTPurposeCyclosporin is administered by intermittent infusions (II) or continuous infusions (CI) to prevent acute graft-versus-host disease (aGVHD). Because cyclosporin disposition is nonlinear, organ exposure may be higher after II than after CI, but saturation of receptors must be accounted for. The aim of the study was to compare both types of administration using a mechanistic model.MethodsA physiologically based pharmacokinetic model was developed to estimate cyclosporin exposure and receptor occupancies (RO) in aGVHD target organs and kidneys and to compare these estimations in pediatric patients that received cyclosporin either by II or CI. The relevant biological parameters were based on a clinical study in 2 groups of pediatric patients that received cyclosporin either by II (n = 31) or CI (n = 30).ResultsSimulations showed that the exposure to cyclosporin in the interstitial fluid of aGVHD target organs was greater at day 1 after II than after CI. In kidneys, the opposite order was observed. AUCRO in all organs was greater after CI than after II. The therapeutic index (the ratio of AUCRO in blood to AUCRO in kidneys) was greater with CI than with II.ConclusionsCI may be slightly more favorable than II for aGVHD prevention.
    32 schema:genre article
    33 schema:isAccessibleForFree false
    34 schema:isPartOf N425056871a514dc3a100640b91c545b1
    35 Nba47a7f7c72342c1998e2e211eea8619
    36 sg:journal.1094644
    37 schema:keywords PBPK model
    38 ResultsSimulations
    39 acute graft
    40 administration
    41 aim
    42 analysis
    43 biological parameters
    44 cell transplantation
    45 clinical studies
    46 continuous infusion
    47 cyclosporin
    48 cyclosporin exposure
    49 day 1
    50 disease
    51 disposition
    52 estimation
    53 exposure
    54 fluid
    55 graft
    56 group
    57 hematopoietic stem cell transplantation
    58 host disease
    59 index
    60 influence
    61 infusion
    62 intermittent infusion
    63 interstitial fluid
    64 kidney
    65 mechanistic model
    66 model
    67 occupancy
    68 opposite order
    69 order
    70 organ exposure
    71 organs
    72 parameters
    73 patients
    74 pediatric hematopoietic stem cell transplantation
    75 pediatric patients
    76 pharmacokinetic model
    77 prevention
    78 receptor occupancy
    79 receptors
    80 relevant biological parameters
    81 saturation
    82 saturation of receptors
    83 schedule
    84 stem cell transplantation
    85 study
    86 target organs
    87 therapeutic index
    88 transplantation
    89 type of administration
    90 types
    91 schema:name Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model
    92 schema:pagination 2602-2613
    93 schema:productId N5b35f28a58f14073bf6ea7584756741a
    94 Nf8095ebd5fcd41348532056c37e42e71
    95 Nfc076a161f98496d96ab84d7e1e43a9e
    96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018143837
    97 https://doi.org/10.1007/s11095-010-0252-1
    98 schema:sdDatePublished 2022-10-01T06:36
    99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    100 schema:sdPublisher Nb193b5892bf5432d9d998aace4c82c3a
    101 schema:url https://doi.org/10.1007/s11095-010-0252-1
    102 sgo:license sg:explorer/license/
    103 sgo:sdDataset articles
    104 rdf:type schema:ScholarlyArticle
    105 N06a00518795e4180b994641bc82579ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Humans
    107 rdf:type schema:DefinedTerm
    108 N09f3b2af4d5a40e19b05fa3d46b3c9b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Tissue Distribution
    110 rdf:type schema:DefinedTerm
    111 N20dd09cba6f04ae79d285a015964d14d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Drug Administration Schedule
    113 rdf:type schema:DefinedTerm
    114 N2cecbeb53e0d46638bb50d0c5e0def6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Animals
    116 rdf:type schema:DefinedTerm
    117 N3a8dc92ea3b0480991e5ca4c3e8cada2 rdf:first sg:person.01250741512.98
    118 rdf:rest Nd7d5b7e3e67e4becb43cf74ed10b2cca
    119 N425056871a514dc3a100640b91c545b1 schema:issueNumber 12
    120 rdf:type schema:PublicationIssue
    121 N552b49c8f2804bbda7270bf0385845c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Graft vs Host Disease
    123 rdf:type schema:DefinedTerm
    124 N5b35f28a58f14073bf6ea7584756741a schema:name doi
    125 schema:value 10.1007/s11095-010-0252-1
    126 rdf:type schema:PropertyValue
    127 N7becbbb0c1cf445c96e16acb628220c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Child
    129 rdf:type schema:DefinedTerm
    130 N7f498f1e2fa74e3cab998661a6fed74a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Hematopoietic Stem Cell Transplantation
    132 rdf:type schema:DefinedTerm
    133 N862bb689b77e47d0a6bbd7bfd9ca84b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Area Under Curve
    135 rdf:type schema:DefinedTerm
    136 N8be64cbf8a56445c89ffd254e874375b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Retrospective Studies
    138 rdf:type schema:DefinedTerm
    139 Na284330ed9004a8081411f2d1b6a1447 rdf:first sg:person.01077622701.25
    140 rdf:rest Na2bdac8181a8445d85893cd8cf1c0629
    141 Na2bdac8181a8445d85893cd8cf1c0629 rdf:first sg:person.0763711421.46
    142 rdf:rest rdf:nil
    143 Nb193b5892bf5432d9d998aace4c82c3a schema:name Springer Nature - SN SciGraph project
    144 rdf:type schema:Organization
    145 Nba47a7f7c72342c1998e2e211eea8619 schema:volumeNumber 27
    146 rdf:type schema:PublicationVolume
    147 Nba89ec5f6b2744fa97c56c9f5fdbbd87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Rats
    149 rdf:type schema:DefinedTerm
    150 Nd7d5b7e3e67e4becb43cf74ed10b2cca rdf:first sg:person.012661201622.56
    151 rdf:rest Ne5b3b29e8d6d440c906dcd469a11dbf3
    152 Ne5b3b29e8d6d440c906dcd469a11dbf3 rdf:first sg:person.0636233052.33
    153 rdf:rest Na284330ed9004a8081411f2d1b6a1447
    154 Ne63a424b16714c9682f21e9e6ec1c175 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Cyclosporine
    156 rdf:type schema:DefinedTerm
    157 Nf8095ebd5fcd41348532056c37e42e71 schema:name pubmed_id
    158 schema:value 20811933
    159 rdf:type schema:PropertyValue
    160 Nfab553ca4c4c483cb816880836519f30 rdf:first sg:person.0660130455.35
    161 rdf:rest N3a8dc92ea3b0480991e5ca4c3e8cada2
    162 Nfc076a161f98496d96ab84d7e1e43a9e schema:name dimensions_id
    163 schema:value pub.1018143837
    164 rdf:type schema:PropertyValue
    165 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    166 schema:name Medical and Health Sciences
    167 rdf:type schema:DefinedTerm
    168 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    169 schema:name Pharmacology and Pharmaceutical Sciences
    170 rdf:type schema:DefinedTerm
    171 sg:journal.1094644 schema:issn 0724-8741
    172 1573-904X
    173 schema:name Pharmaceutical Research
    174 schema:publisher Springer Nature
    175 rdf:type schema:Periodical
    176 sg:person.01077622701.25 schema:affiliation grid-institutes:grid.452431.5
    177 schema:familyName Bertrand
    178 schema:givenName Yves
    179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25
    180 rdf:type schema:Person
    181 sg:person.01250741512.98 schema:affiliation grid-institutes:grid.7849.2
    182 schema:familyName Bleyzac
    183 schema:givenName Nathalie
    184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250741512.98
    185 rdf:type schema:Person
    186 sg:person.012661201622.56 schema:affiliation grid-institutes:grid.7849.2
    187 schema:familyName Girard
    188 schema:givenName Pascal
    189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661201622.56
    190 rdf:type schema:Person
    191 sg:person.0636233052.33 schema:affiliation grid-institutes:grid.7849.2
    192 schema:familyName Freyer
    193 schema:givenName Gilles
    194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636233052.33
    195 rdf:type schema:Person
    196 sg:person.0660130455.35 schema:affiliation grid-institutes:grid.7849.2
    197 schema:familyName Gérard
    198 schema:givenName Cécile
    199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660130455.35
    200 rdf:type schema:Person
    201 sg:person.0763711421.46 schema:affiliation grid-institutes:grid.413306.3
    202 schema:familyName Tod
    203 schema:givenName Michel
    204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763711421.46
    205 rdf:type schema:Person
    206 sg:pub.10.1007/bf01062191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052427388
    207 https://doi.org/10.1007/bf01062191
    208 rdf:type schema:CreativeWork
    209 sg:pub.10.1007/bf02353860 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015648303
    210 https://doi.org/10.1007/bf02353860
    211 rdf:type schema:CreativeWork
    212 sg:pub.10.1016/s0009-9236(99)70055-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001636599
    213 https://doi.org/10.1016/s0009-9236(99)70055-x
    214 rdf:type schema:CreativeWork
    215 sg:pub.10.1023/a:1020978509566 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031758240
    216 https://doi.org/10.1023/a:1020978509566
    217 rdf:type schema:CreativeWork
    218 sg:pub.10.1038/35077251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023027862
    219 https://doi.org/10.1038/35077251
    220 rdf:type schema:CreativeWork
    221 sg:pub.10.1038/sj.bmt.1700745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005934101
    222 https://doi.org/10.1038/sj.bmt.1700745
    223 rdf:type schema:CreativeWork
    224 sg:pub.10.1038/sj.bmt.1701396 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043707730
    225 https://doi.org/10.1038/sj.bmt.1701396
    226 rdf:type schema:CreativeWork
    227 sg:pub.10.1038/sj.bmt.1701954 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039560833
    228 https://doi.org/10.1038/sj.bmt.1701954
    229 rdf:type schema:CreativeWork
    230 sg:pub.10.1038/sj.bmt.1704213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038017388
    231 https://doi.org/10.1038/sj.bmt.1704213
    232 rdf:type schema:CreativeWork
    233 sg:pub.10.1038/sj.bmt.1704239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002246124
    234 https://doi.org/10.1038/sj.bmt.1704239
    235 rdf:type schema:CreativeWork
    236 sg:pub.10.1038/sj.bmt.1705481 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050679665
    237 https://doi.org/10.1038/sj.bmt.1705481
    238 rdf:type schema:CreativeWork
    239 sg:pub.10.2165/00003088-200645090-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017122603
    240 https://doi.org/10.2165/00003088-200645090-00005
    241 rdf:type schema:CreativeWork
    242 sg:pub.10.2165/00003088-200645100-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037331185
    243 https://doi.org/10.2165/00003088-200645100-00005
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.2165/00003088-200746050-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016219511
    246 https://doi.org/10.2165/00003088-200746050-00004
    247 rdf:type schema:CreativeWork
    248 grid-institutes:grid.413306.3 schema:alternateName Pharmacie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 103 Grande rue de la Croix-Rousse, 69317, Lyon cedex 04, France
    249 schema:name Faculté de Médecine Lyon Sud, Université Lyon 1, EA3738, CTO, F-69600, Oullins, France
    250 Pharmacie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 103 Grande rue de la Croix-Rousse, 69317, Lyon cedex 04, France
    251 Université de Lyon, F-69003, Lyon, France
    252 rdf:type schema:Organization
    253 grid-institutes:grid.452431.5 schema:alternateName Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, France
    254 schema:name Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, France
    255 rdf:type schema:Organization
    256 grid-institutes:grid.7849.2 schema:alternateName Faculté de Médecine Lyon Sud, Université Lyon 1, EA3738, CTO, F-69600, Oullins, France
    257 Faculté de Médecine, Université Lyon 1, CNRS UMR5558, F-69008, Lyon, France
    258 schema:name Faculté de Médecine Lyon Sud, Université Lyon 1, EA3738, CTO, F-69600, Oullins, France
    259 Faculté de Médecine, Université Lyon 1, CNRS UMR5558, F-69008, Lyon, France
    260 Institut d’Hématologie et d’Oncologie Pédiatrique, Lyon, France
    261 Université de Lyon, F-69003, Lyon, France
    262 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...